Adicet Bio

Redwood City, United States

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Oct 2025

Post-IPO Equity

Top Investors

OrbiMedRegeneronPontifaxNovartis Venture FundKB Investment

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Adicet Bio's investors?

Adicet Bio's investors include OrbiMed, Regeneron, Pontifax, Novartis Venture Fund, KB Investment.

Where is Adicet Bio headquartered?

Adicet Bio is headquartered in Redwood City, United States.

What does Adicet Bio do?

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

What stage is Adicet Bio at?

Adicet Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 7, 2025.

MLA

"Adicet Bio — Funding & Investors." VCBacked, October 7, 2025, https://www.vcbacked.co/company/adicet-bio. Accessed July 1, 2026.

APA

VCBacked. (2025). Adicet Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/adicet-bio

Wikipedia (cite web)

{{cite web |title=Adicet Bio — Funding & Investors |url=https://www.vcbacked.co/company/adicet-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 7, 2025.